These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

229 related articles for article (PubMed ID: 9636865)

  • 1. A double-blind comparison of itraconazole oral solution and fluconazole capsules for the treatment of oropharyngeal candidiasis in patients with AIDS.
    Phillips P; De Beule K; Frechette G; Tchamouroff S; Vandercam B; Weitner L; Hoepelman A; Stingl G; Clotet B
    Clin Infect Dis; 1998 Jun; 26(6):1368-73. PubMed ID: 9636865
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Randomized trial of itraconazole oral solution for oropharyngeal candidiasis in HIV/AIDS patients.
    Graybill JR; Vazquez J; Darouiche RO; Morhart R; Greenspan D; Tuazon C; Wheat LJ; Carey J; Leviton I; Hewitt RG; MacGregor RR; Valenti W; Restrepo M; Moskovitz BL
    Am J Med; 1998 Jan; 104(1):33-9. PubMed ID: 9528717
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Safety and efficacy of single-dose fluconazole compared with a 7-day regimen of itraconazole in the treatment of AIDS-related oropharyngeal candidiasis.
    De Wit S; O'Doherty E; De Vroey C; Clumeck N
    J Int Med Res; 1998; 26(3):159-70. PubMed ID: 9718471
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment of fluconazole-refractory oropharyngeal candidiasis with itraconazole oral solution in HIV-positive patients.
    Saag MS; Fessel WJ; Kaufman CA; Merrill KW; Ward DJ; Moskovitz BL; Thomas C; Oleka N; Guarnieri JA; Lee J; Brenner-Gati L; Klausner M
    AIDS Res Hum Retroviruses; 1999 Nov; 15(16):1413-7. PubMed ID: 10555103
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fluconazole vs itraconazole-flucytosine association in the treatment of esophageal candidiasis in AIDS patients. A double-blind, multicenter placebo-controlled study. The Candida Esophagitis Multicenter Italian Study (CEMIS) Group.
    Barbaro G; Barbarini G; Di Lorenzo G
    Chest; 1996 Dec; 110(6):1507-14. PubMed ID: 8989069
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Itraconazole cyclodextrin solution for fluconazole-refractory oropharyngeal candidiasis in AIDS: correlation of clinical response with in vitro susceptibility.
    Phillips P; Zemcov J; Mahmood W; Montaner JS; Craib K; Clarke AM
    AIDS; 1996 Oct; 10(12):1369-76. PubMed ID: 8902066
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of itraconazole and ketoconazole in HIV-positive patients with oropharyngeal or esophageal candidiasis. Human Immunodeficiency Virus Itraconazole Ketoconazole Project Group.
    de Repentigny L; Ratelle J
    Chemotherapy; 1996; 42(5):374-83. PubMed ID: 8874977
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical trial: clotrimazole troche vs. itraconazole oral solution in the treatment of oral candidosis in AIDS patients.
    Linpiyawan R; Jittreprasert K; Sivayathorn A
    Int J Dermatol; 2000 Nov; 39(11):859-61. PubMed ID: 11123451
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of efficacy and safety of itraconazole oral solution for the treatment of oropharyngeal candidiasis in aids patients.
    Queiroz-Telles F; Silva N; Carvalho MM; Alcântara AP; da Matta D; Barberino MG; Bartczak S; Colombo AL
    Braz J Infect Dis; 2001 Apr; 5(2):60-6. PubMed ID: 11493410
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fluconazole compared with itraconazole in the treatment of esophageal candidiasis in AIDS patients: a double-blind, randomized, controlled clinical study.
    Barbaro G; Barbarini G; Di Lorenzo G
    Scand J Infect Dis; 1995; 27(6):613-7. PubMed ID: 8685642
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Itraconazole suspension in the treatment of HIV-infected patients with fluconazole-resistant oropharyngeal candidiasis and esophagitis].
    Eichel M; Just-Nübling G; Helm EB; Stille W
    Mycoses; 1996; 39 Suppl 1():102-6. PubMed ID: 8767280
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Single-dose fluconazole versus standard 2-week therapy for oropharyngeal candidiasis in HIV-infected patients: a randomized, double-blind, double-dummy trial.
    Hamza OJ; Matee MI; Brüggemann RJ; Moshi MJ; Simon EN; Mugusi F; Mikx FH; van der Lee HA; Verweij PE; van der Ven AJ
    Clin Infect Dis; 2008 Nov; 47(10):1270-6. PubMed ID: 18840077
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The efficacy of fluconazole 600 mg/day versus itraconazole 600 mg/day as consolidation therapy of cryptococcal meningitis in AIDS patients.
    Mootsikapun P; Chetchotisakd P; Anunnatsiri S; Choksawadphinyo K
    J Med Assoc Thai; 2003 Apr; 86(4):293-8. PubMed ID: 12757072
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of therapeutic activity of fluconazole and itraconazole in the treatment of oesophageal candidiasis in AIDS patients: a double-blind, randomized, controlled clinical study.
    Barbaro G; Di Lorenzo G
    Ital J Gastroenterol; 1995 May; 27(4):175-80. PubMed ID: 8520033
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A randomized, double-blind comparison of itraconazole oral solution and fluconazole tablets in the treatment of esophageal candidiasis.
    Wilcox CM; Darouiche RO; Laine L; Moskovitz BL; Mallegol I; Wu J
    J Infect Dis; 1997 Jul; 176(1):227-32. PubMed ID: 9207371
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A comparison of fluconazole and itraconazole in the management of denture stomatitis: a pilot study.
    Cross LJ; Bagg J; Wray D; Aitchison T
    J Dent; 1998 Nov; 26(8):657-64. PubMed ID: 9793287
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An open multicentre comparative study of the efficacy, safety and tolerance of fluconazole and itraconazole in the treatment of cancer patients with oropharyngeal candidiasis.
    Oude Lashof AM; De Bock R; Herbrecht R; de Pauw BE; Krcmery V; Aoun M; Akova M; Cohen J; Siffnerová H; Egyed M; Ellis M; Marinus A; Sylvester R; Kullberg BJ;
    Eur J Cancer; 2004 Jun; 40(9):1314-9. PubMed ID: 15177489
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Posaconazole for the treatment of azole-refractory oropharyngeal and esophageal candidiasis in subjects with HIV infection.
    Skiest DJ; Vazquez JA; Anstead GM; Graybill JR; Reynes J; Ward D; Hare R; Boparai N; Isaacs R
    Clin Infect Dis; 2007 Feb; 44(4):607-14. PubMed ID: 17243069
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An open-label randomized trial comparing itraconazole oral solution with fluconazole oral solution for primary prophylaxis of fungal infections in patients with haematological malignancy and profound neutropenia.
    Glasmacher A; Cornely O; Ullmann AJ; Wedding U; Bodenstein H; Wandt H; Boewer C; Pasold R; Wolf HH; Hänel M; Dölken G; Junghanss C; Andreesen R; Bertz H;
    J Antimicrob Chemother; 2006 Feb; 57(2):317-25. PubMed ID: 16339606
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy of melaleuca oral solution for the treatment of fluconazole refractory oral candidiasis in AIDS patients.
    Jandourek A; Vaishampayan JK; Vazquez JA
    AIDS; 1998 Jun; 12(9):1033-7. PubMed ID: 9662200
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.